Some small studies show that low-dose rapamycin may improve immune function and markers of aging, but the results are inconsistent and based on limited data, according to the researchers.

Innovative therapies, including BTK inhibitors, target multiple sclerosis progression, offering hope for improved treatment ...

As a former Type 2 diabetic, I learned firsthand how dramatically diet can affect your health. Twenty years ago, I was able to reverse my diagnosis in just three months by cutting back on ...

A groundbreaking study has revealed that fotagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, significantly enhances ...

The common diabetes drug metformin can protect against dementia and Alzheimer’s in overweight and obese adults, according to new research published in the journal Diabetes, Obesity and Metabolism. The ...

The addition of fotagliptin to metformin treatment shows enhanced and clinically meaningful glycemic control in patients with ...

Vistin Pharma ASA will release its second quarter and YTD 2025 results on Friday 15th of August 2025. Vistin Pharma will host a conference call for all shareholders and interested parties at the same ...

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 37 essential drug formulations, spanning antibiotics, painkillers, cardiovascular, respiratory and diabetes medicines ...

For older adults with type 2 diabetes, GLP-1 RA use is associated with nonarteritic anterior ischemic optic neuropathy.

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not ...

The dulaglutide biosimilar LY05008 demonstrated equivalent efficacy in reducing HbA1c, along with comparable safety and immunogenicity profiles, to the reference drug dulaglutide in Chinese adults ...

Illnesses like high blood pressure, diabetes, and glaucoma have hardly any symptoms until the damage has been done.